[Retracted] Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Factors</td><td class="align_center">Variables</td><td class="align_center">Assignment</td></tr><tr><td class="align_left" colspan="3"><hr/></td></tr><tr><td class="align_left">Pathological grade</td><td class="align_center"><i>X</i>1</td><td class="align_center">Medium-high differentiation = 0; poor differentiation = 1</td></tr><tr><td class="align_left">Peritoneal metastasis</td><td class="align_center"><i>X</i>2</td><td class="align_center">No = 0; yes = 1</td></tr><tr><td class="align_left">Chemotherapy regimen</td><td class="align_center"><i>X</i>3</td><td class="align_center">mFOLFOX6 + cetuximab = 0; mFOLFOX6 + cetuximab + simvastatin = 1</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Assignment for multivariate analysis of factors.</div>

Evidence-Based Complementary and Alternative Medicine

tab5

Table 5

Table 5: [Retracted] Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer 

Table 5 | [Retracted] Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer 